Correlating metabolic activity with cellular proliferation in follicular lymphomas

Molecular Imaging and Biology

Volumn 11, Issue 5, 2009, Pages 296-302

  Tang, Bingfeng ^a   Malysz, Jozef ^a   Douglas Nikitin, Vonda ^a   Zekman, Richard ^a   Wong, Regina Heather ^a   Jaiyesimi, Ishmael ^a   Wong, Ching Yee Oliver ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Bone marrow; Follicular lymphoma; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MONOCLONAL ANTIBODY KI 67;

ARTICLE; CANCER GRADING; CELL PROLIFERATION; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORRELATION ANALYSIS; DRUG UPTAKE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; METABOLISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT PLANNING; TUMOR BIOPSY;

BIOPSY; CELL GROWTH PROCESSES; FLUORODEOXYGLUCOSE F18; HUMANS; KI-67 ANTIGEN; LYMPHOMA, FOLLICULAR; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; WHOLE BODY IMAGING;

EID: 68449090032     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-009-0226-z     Document Type: Article

References (13)

1. Kumar R, Maillard I, Schuster DJ et al (2004) Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin North Am 42:1083-1100
2. Burton C, Ell P, Linch D (2004) The role of PET imaging in lymphoma. Br J Haematol 126:772-784
3. The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89:3909-3918
4. Lu P (2005) Staging and classification of lymphoma. Semin Nucl Med 35:160-164
5. Gerdes J, Schwab U, Lemke H et al (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13-20
6. Bryant RJ, Banks PM, O'Malley DP (2006) Ki67 staining pattern as a diagnostic tool in the evaluation of lymphoproliferative disorders. Histopathology 48:505-515
7. Wirth A, Foo M, Seymour JF et al (2008) Impact of 18F-fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 71:213-219
8. Karam M, Novak L, Cyriac J et al (2006) Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer 107:175-183
9. Wong CYO, Thie J, Parling-Lynch KJ et al (2007) Investigating the existence of quantum metabolic values in non-Hodgkin's lymphoma by F-18 FDG. Mol Imaging Biol 9(1):43-49
10. Wong CYO, Thie J, Parling-Lynch KJ, Zakalik D, Margolis JH, Qing F, Fink-Bennett D, Nagle C (2005) Glucose-normalized standard uptake value (SUV) from F-18 FDG PET in classifying lymphomas. J Nucl Med 46(10):1659-1663
11. Wohrer S, Jaeger U, Kletter K et al (2006) 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Annals of Oncol 17:780-784
12. Schoder H, Noy A, Gonen M et al (2005) Intensity of 18Fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol 23:4643-4651
13. Allen-Auerbach M, Quon A, Weber WA et al (2004) Comparison between 2-deoxy-2-[(18)F]Fluoro-D-glucose positron-emission tomography and positron-emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol 6:411-416